Brian Cohen, MD
Orthopaedic Surgery · Providence, RINPI 1932546058
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $32,493 with a category attached, or 61.6%. Arthrex accounts for 62.1% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $25,339 and has fallen 99.7% since, to $82 in 2025.
Across 49 payments — averaging $663.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$20K
- Smith+Nephew$10K
- Stryker$762
- Medical Device Business Services, Inc.$689
- Dynasplint Systems Inc.$167
- Ferring Pharmaceuticals Inc.$113
- plus $439 from 12 others
What the payments were for
- Grants$20,00062%
- Travel & lodging$1620%
- Food & beverage$1,6175%
- Education$10,71433%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 3 | $20,180 |
| Smith+Nephew | 5 | $10,142 |
| Stryker | 11 | $762 |
| Medical Device Business Services, Inc. | 4 | $689 |
| Dynasplint Systems Inc. | 1 | $167 |
| Ferring Pharmaceuticals Inc. | 6 | $113 |
| Bioventus LLC | 3 | $86 |
| Pacira Therapeutics, Inc. | 4 | $84 |
| Johnson & Johnson(2 entities) | 2 | $51 |
| Pacira Pharmaceuticals Incorporated | 2 | $40 |
| Linvatec Corporation | 1 | $28 |
| Osteomed LLC | 1 | $25 |
| EBI, LLC | 1 | $24 |
| Zimmer Biomet | 1 | $24 |
| AbbVie | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dynasplint$167
- NA$152
- INSPACE$140
How this compares
$32,493 in reported general payments places this provider in the 80th percentile of 124 orthopaedic surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 52 | $808 |
| Methylprednisolone | 67 | $570 |
| Meloxicam | 46 | $255 |
| Oxycodone Hcl | 26 | $129 |
| Naproxen | 15 | $81 |
| Tramadol Hcl | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Providence
- Edward PaxtonProvidence$244K
- Steven BokshanProvidence$130K
- Eric CohenProvidence$72K
- Erin HaggertyProvidence$67K
- Todd BorensteinProvidence$49K
- Mark PalumboProvidence$39K
- Scott MallozziProvidence$28K
- Peter WagnerProvidence$26K
- Craig EbersonProvidence$26K
- Jeremy TruntzerProvidence$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.